TearLab Wins Silver Medical Design Excellence Award
TearLab Corporation of San Diego announced that its TearLab Osmolarity System has received a Silver 2009 Medical Design Excellence Award.
Articles by bjohnson56
Positive Results for Human Genome’s Lupus Drug Benlysta
Biotechnology company Human Genome Sciences reported that its drug candidate Benlysta reduced symptoms of lupus in a long-term clinical trial.
Less Than Two Weeks Until IN3 East
Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker BioVentures, Siemens Venture Capital, Stryker […]
NeuroSearch’s Tesofensine Advances to Phase III Testing
Yesterday, OneMedPlace reported on several companies that are developing anti-obesity drugs. Another name can be added to the list.
VIVUS’ Qnexa Shows Promise For Diabetics
VIVUS, a pharmaceutical company specializing in products to treat sexual function, announced that their experimental obesity drug Qnexa was shown to improve blood sugar control in patients with type 2 diabetes.
Correction: Sentinel – Symphony Medical
In last week’s Sentinel, OneMedPlace reported that Symphony Medical had initiated a Phase II clinical trial of their Plexisyl-AF device to treat atrial fibrillation.
HealthTronics to Buy Endocare
HealthTronics announced that it has entered into a definitive merger agreement with Endocare.
Companies Rush to Create Swine Flu Vaccines
With flu season approaching, the U.S. federal government has earmarked nearly $1 billion for the development of swine flu vaccines.
Medtronic Acquires Diabetes Tech from PreciSense
Medtronic announced at its annual investor meeting that it has acquired substantially all glucose monitoring technology from Danish company PreciSense.
Sensimed Honored With Red Herring Award
Sensimed, a Swiss company focused on the development of integrated micro-systems for medical devices, has received the Red Herring 100 Europe 2009 Award.